The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
Dosage form
Solution for injection 5 ml №10 or 10 ml №10.
Active ingredient
1 ml of the solution contains 25 mg of morpholine salt of tiazotic acid on 100% substance basis, which is equivalent to 16.6 mg of the tiazotic acid, 100 mg of piracetam.
Indications
Treatment of ischemic stroke and its consequences, such as speech disorders, mental and somatic illnesses, decreased activity, emotional disorders; treatment (in the rehabilitation period) of the vascular, toxic and traumatic encephalopathy; treatment of alcohol withdrawal syndrome, diabetic encephalopathy; hypersensitivity to tiazotic acid and/or piracetam; end-stage of renal disease; Huntington's disease; hemorrhagic stroke.

If you have information about any adverse effects or other drug-related problems, please fill in the form